Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexxar Consolidation in Multiple Myeloma
NCT00135200Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Aug 2005
- Primary completion
- Aug 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of iodine i 131 tositumomab in multiple myeloma (MM), sponsored by University of Michigan Rogel Cancer Center. Started Aug 2005; status: completed.
02
Drugs
iodine i 131 tositumomab
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00135200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135200.